CS logo
small CS logo
Brown University, Women & Infants Hospital of Rhode Island

Providence, Rhode Island, United States
Hospital in Providence, Rhode Island
101 Dudley St, Providence, RI 02905
137 Beds

About Brown University, Women & Infants Hospital of Rhode Island


Women & Infants Hospital of Rhode Island is a women and infants' hospital in Providence, Rhode Island. It is the primary teaching hospital in obstetrics, gynecology, and newborn pediatrics of the Warren Alpert Medical School at Brown University.
There are 137 beds in Brown University, Women & Infants Hospital of Rhode Island.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Brown University, Women & Infants Hospital of Rhode Island


During the past decade, Brown University, Women & Infants Hospital of Rhode Island conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 12 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Brown University, Women & Infants Hospital of Rhode Island" #1 collaborator was "National Center for Research Resources (NCRR)" with 37 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 31 trials as a collaborator, "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Centers for Disease Control and Prevention" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

Clinical Trials Conditions at Brown University, Women & Infants Hospital of Rhode Island


According to Clinical.Site data, the most researched conditions in "Brown University, Women & Infants Hospital of Rhode Island" are "Infant, Newborn" (40 trials), "Infant, Small for Gestational Age" (30 trials), "Infant, Premature" (29 trials), "Infant, Low Birth Weight" (25 trials) and "Bronchopulmonary Dysplasia (BPD)" (6 trials). Many other conditions were trialed in "Brown University, Women & Infants Hospital of Rhode Island" in a lesser frequency.

Clinical Trials Intervention Types at Brown University, Women & Infants Hospital of Rhode Island


Most popular intervention types in "Brown University, Women & Infants Hospital of Rhode Island" are "Drug" (24 trials), "Procedure" (10 trials), "Device" (4 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Hydrocortisone" (2 trials), "Hypothermia" (2 trials), "Inhaled nitric oxide" (2 trials) and "Inositol lower volume" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Brown University, Women & Infants Hospital of Rhode Island


The vast majority of trials in "Brown University, Women & Infants Hospital of Rhode Island" are 51 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Brown University, Women & Infants Hospital of Rhode Island


Currently, there are NaN active trials in "Brown University, Women & Infants Hospital of Rhode Island". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Brown University, Women & Infants Hospital of Rhode Island, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Brown University, Women & Infants Hospital of Rhode Island, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".